Potential Parkinson’s dementia therapy, NYX-458, fails in Phase 2 trial | Safety seen in patients but efficacy measures … – Parkinson’s News Today
Potential Parkinson’s dementia therapy, NYX-458, fails in Phase 2 trial | Safety seen in patients but efficacy measures … Parkinson’s News Today
Discussion disabled.
Category: Dementia